Rezolute, Inc. (RZLT)
4.22
+0.05
(+1.20%)
USD |
NASDAQ |
Sep 11, 16:00
4.21
-0.01
(-0.24%)
After-Hours: 20:00
Rezolute Price : 4.22 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 4.23 | 4.355 | 4.08 | 4.22 | 1.353M |
| Sep 10, 2026 | 4.03 | 4.35 | 3.97 | 4.17 | 2.225M |
| Sep 09, 2026 | 4.55 | 4.55 | 4.02 | 4.06 | 2.074M |
| Sep 08, 2026 | 4.51 | 4.53 | 4.37 | 4.40 | 867085.0 |
| Sep 04, 2026 | 4.49 | 4.62 | 4.44 | 4.58 | 716948.0 |
| Sep 03, 2026 | 4.59 | 4.615 | 4.47 | 4.54 | 771933.0 |
| Sep 02, 2026 | 4.50 | 4.61 | 4.43 | 4.56 | 857320.0 |
| Sep 01, 2026 | 4.64 | 4.71 | 4.43 | 4.50 | 1.021M |
| Aug 31, 2026 | 4.65 | 4.74 | 4.60 | 4.69 | 749091.0 |
| Aug 28, 2026 | 4.95 | 4.95 | 4.58 | 4.62 | 1.085M |
| Aug 27, 2026 | 5.07 | 5.081 | 4.935 | 4.98 | 784235.0 |
| Aug 26, 2026 | 5.01 | 5.10 | 4.875 | 5.04 | 1.368M |
| Aug 25, 2026 | 4.94 | 5.22 | 4.94 | 5.01 | 1.799M |
| Aug 24, 2026 | 5.03 | 5.13 | 4.70 | 5.01 | 1.297M |
| Aug 21, 2026 | 4.68 | 5.635 | 4.646 | 5.09 | 6.501M |
| Aug 20, 2026 | 4.68 | 4.71 | 4.60 | 4.66 | 971465.0 |
| Aug 19, 2026 | 4.77 | 4.87 | 4.65 | 4.72 | 1.220M |
| Aug 18, 2026 | 4.62 | 4.72 | 4.58 | 4.66 | 912778.0 |
| Aug 17, 2026 | 4.58 | 4.695 | 4.56 | 4.68 | 535242.0 |
| Aug 14, 2026 | 4.59 | 4.75 | 4.44 | 4.60 | 657137.0 |
| Aug 13, 2026 | 4.74 | 4.885 | 4.58 | 4.60 | 800613.0 |
| Aug 12, 2026 | 4.65 | 4.805 | 4.62 | 4.70 | 2.391M |
| Aug 11, 2026 | 4.68 | 4.725 | 4.61 | 4.62 | 641978.0 |
| Aug 10, 2026 | 4.68 | 4.760 | 4.595 | 4.68 | 756464.0 |
| Aug 07, 2026 | 4.76 | 4.840 | 4.545 | 4.69 | 986261.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| SELLAS Life Sciences Group, Inc. | 11.54 |
| AbbVie, Inc. | 257.12 |
| Marker Therapeutics, Inc. | 1.15 |
| Avalo Therapeutics, Inc. | 16.12 |
| Krystal Biotech, Inc. | 347.00 |
Price Related Metrics
| Price to Book Value | 3.478 |
| Earnings Yield | -19.17% |
| Market Cap | 406.35M |